140 related articles for article (PubMed ID: 16275211)
1. Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study.
Gaite L; Vázquez-Barquero JL; Herrán A; Thornicroft G; Becker T; Sierra-Biddle D; Ruggeri M; Schene A; Knapp M; Vázquez-Bourgon J;
Compr Psychiatry; 2005; 46(6):440-6. PubMed ID: 16275211
[TBL] [Abstract][Full Text] [Related]
2. [Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].
Rafrafi R; Zaghdoudi L; Mahbouli M; Bouzid R; Labbane R; El Hechmi Z
Encephale; 2009 Jun; 35(3):234-40. PubMed ID: 19540409
[TBL] [Abstract][Full Text] [Related]
3. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
4. Facial expressivity during the clinical interview as a predictor functional disability in schizophrenia. a pilot study.
Troisi A; Pompili E; Binello L; Sterpone A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):475-81. PubMed ID: 17188789
[TBL] [Abstract][Full Text] [Related]
5. Relation between social functioning and neurocognitive test results using the Optional Thinking Test in schizophrenia.
Chino B; Mizuno M; Nemoto T; Yamashita C; Kashima H
Psychiatry Clin Neurosci; 2006 Feb; 60(1):63-9. PubMed ID: 16472360
[TBL] [Abstract][Full Text] [Related]
6. Contribution of divergent thinking to community functioning in schizophrenia.
Nemoto T; Kashima H; Mizuno M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):517-24. PubMed ID: 17218048
[TBL] [Abstract][Full Text] [Related]
7. The actual process of rating the global assessment of functioning scale.
Yamauchi K; Ono Y; Baba K; Ikegami N
Compr Psychiatry; 2001; 42(5):403-9. PubMed ID: 11559867
[TBL] [Abstract][Full Text] [Related]
8. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
[TBL] [Abstract][Full Text] [Related]
9. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
[TBL] [Abstract][Full Text] [Related]
10. [Predictors of social functioning in schizophrenia].
Erol A; Keleş Unal E; Tunç Aydin E; Mete L
Turk Psikiyatri Derg; 2009; 20(4):313-21. PubMed ID: 20013422
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
[TBL] [Abstract][Full Text] [Related]
12. Global assessment of psychosocial functioning and predictors of outcome in schizophrenia.
Stefanopoulou E; Lafuente AR; Fonseca AS; Keegan S; Vishnick C; Huxley A
Int J Psychiatry Clin Pract; 2011 Mar; 15(1):62-8. PubMed ID: 22122691
[TBL] [Abstract][Full Text] [Related]
13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
14. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and functioning ability in subjects vulnerable to psychosis.
Svirskis T; Korkeila J; Heinimaa M; Huttunen J; Ilonen T; Ristkari T; Hietala J; Syvälahti E; McGlashan T; Vahlberg T; Salokangas RK
Compr Psychiatry; 2007; 48(2):155-60. PubMed ID: 17292706
[TBL] [Abstract][Full Text] [Related]
16. [Insight in schizophrenia: assessment of 31 patients with different scales].
Travers D; Levoyer D; Millet B
Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
[TBL] [Abstract][Full Text] [Related]
17. Cognition and global assessment of functioning in male and female outpatients with schizophrenia spectrum disorders.
Karilampi U; Helldin L; Archer T
J Nerv Ment Dis; 2011 Jul; 199(7):445-8. PubMed ID: 21716056
[TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of DSM-IV Axis V scales in a clinical sample of veterans with posttraumatic stress disorder.
Jovanović AA; Gasić MJ; Ivković M; Milovanović S; Damjanović A
Psychiatr Danub; 2008 Sep; 20(3):286-300. PubMed ID: 18827754
[TBL] [Abstract][Full Text] [Related]
19. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
20. Autonomic nervous system activity and psychiatric severity in schizophrenia.
Fujibayashi M; Matsumoto T; Kishida I; Kimura T; Ishii C; Ishii N; Moritani T
Psychiatry Clin Neurosci; 2009 Aug; 63(4):538-45. PubMed ID: 19496998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
